Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Equus caballus | Ferritin light chain | Starlite/ChEMBL | No references |
Rattus norvegicus | Adrenergic receptor alpha-1 | Starlite/ChEMBL | References |
Homo sapiens | GNAS complex locus | Starlite/ChEMBL | No references |
Homo sapiens | lamin A/C | Starlite/ChEMBL | No references |
Rattus norvegicus | Serotonin 1a (5-HT1a) receptor | Starlite/ChEMBL | References |
Homo sapiens | arachidonate 15-lipoxygenase, type B | Starlite/ChEMBL | No references |
Rattus norvegicus | Dopamine D2 receptor | Starlite/ChEMBL | References |
Homo sapiens | l(3)mbt-like 1 (Drosophila) | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | lamin dm0 | 0.0033 | 0.0454 | 0.0431 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0055 | 0.1136 | 0.2535 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.1136 | 0.0963 |
Echinococcus granulosus | biogenic amine 5HT receptor | 0.0159 | 0.4241 | 0.6631 |
Echinococcus multilocularis | serotonin receptor | 0.0159 | 0.4241 | 0.6631 |
Echinococcus granulosus | intermediate filament protein | 0.0033 | 0.0454 | 0.0431 |
Loa Loa (eye worm) | hypothetical protein | 0.0159 | 0.4241 | 0.9464 |
Brugia malayi | mbt repeat family protein | 0.0058 | 0.1207 | 0.2694 |
Brugia malayi | Ras protein let-60 | 0.0167 | 0.4481 | 1 |
Echinococcus granulosus | arachidonate 5 lipoxygenase | 0.0142 | 0.3756 | 0.5838 |
Trichomonas vaginalis | rap1 and, putative | 0.0167 | 0.4481 | 0.5 |
Echinococcus granulosus | SAM and MBT domain containing protein | 0.0058 | 0.1207 | 0.1663 |
Onchocerca volvulus | Polycomb protein Sfmbt homolog | 0.0058 | 0.1207 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0066 | 0.1447 | 0.3228 |
Brugia malayi | hypothetical protein | 0.0024 | 0.0191 | 0.0427 |
Echinococcus granulosus | lamin dm0 | 0.0033 | 0.0454 | 0.0431 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0033 | 0.0454 | 0.1014 |
Loa Loa (eye worm) | doublecortin family protein | 0.0024 | 0.0191 | 0.0427 |
Schistosoma mansoni | scm-relatedprotein containing 4 mbt domains (sfmbt) | 0.0058 | 0.1207 | 0.1035 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.0191 | 0.0427 |
Echinococcus multilocularis | endonuclease exonuclease phosphatase | 0.0227 | 0.6298 | 1 |
Brugia malayi | Doublecortin family protein | 0.0024 | 0.0191 | 0.0427 |
Entamoeba histolytica | Ras family GTPase | 0.0167 | 0.4481 | 0.5 |
Trichomonas vaginalis | dexras1, putative | 0.0167 | 0.4481 | 0.5 |
Echinococcus granulosus | suppression of tumorigenicity 18 protein | 0.0066 | 0.1447 | 0.2056 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.1136 | 0.0963 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.1136 | 0.1547 |
Brugia malayi | mbt repeat family protein | 0.0058 | 0.1207 | 0.2694 |
Trichomonas vaginalis | ras-dva small GTPase, putative | 0.0167 | 0.4481 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.0191 | 0.0427 |
Echinococcus granulosus | endonuclease exonuclease phosphatase | 0.0227 | 0.6298 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0159 | 0.4241 | 0.9464 |
Loa Loa (eye worm) | hypothetical protein | 0.0167 | 0.4481 | 1 |
Loa Loa (eye worm) | intermediate filament protein | 0.0033 | 0.0454 | 0.1014 |
Loa Loa (eye worm) | mbt repeat family protein | 0.0058 | 0.1207 | 0.2694 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.0437 | 0.0974 |
Schistosoma mansoni | myelin transcription factor 1 myt1 | 0.0066 | 0.1447 | 0.128 |
Trichomonas vaginalis | ral, putative | 0.0167 | 0.4481 | 0.5 |
Schistosoma mansoni | sex comb on midleg homolog | 0.0058 | 0.1207 | 0.1035 |
Echinococcus multilocularis | arachidonate 5 lipoxygenase | 0.0142 | 0.3756 | 0.5838 |
Onchocerca volvulus | 0.0033 | 0.0454 | 0.2591 | |
Entamoeba histolytica | ras-1, putative | 0.0167 | 0.4481 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.1136 | 0.0963 |
Echinococcus granulosus | polycomb protein SCMH1 | 0.0058 | 0.1207 | 0.1663 |
Echinococcus granulosus | histone acetyltransferase MYST2 | 0.0066 | 0.1447 | 0.2056 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0055 | 0.1136 | 0.2535 |
Echinococcus granulosus | ras gtpase | 0.0167 | 0.4481 | 0.7024 |
Brugia malayi | Ras-related protein R-Ras2 | 0.0167 | 0.4481 | 1 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.1136 | 0.1547 |
Brugia malayi | C2-HC type zinc finger protein C.e-MyT1 | 0.0066 | 0.1447 | 0.3228 |
Plasmodium falciparum | LCCL domain-containing protein | 0.0024 | 0.0191 | 0.5 |
Trichomonas vaginalis | rheb, putative | 0.0167 | 0.4481 | 0.5 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.1136 | 0.1547 |
Schistosoma mansoni | sex comb on midleg homolog | 0.0058 | 0.1207 | 0.1035 |
Echinococcus multilocularis | musashi | 0.0033 | 0.0454 | 0.0431 |
Brugia malayi | intermediate filament protein | 0.0033 | 0.0454 | 0.1014 |
Schistosoma mansoni | lamin | 0.0033 | 0.0454 | 0.0268 |
Onchocerca volvulus | 0.0058 | 0.1207 | 1 | |
Echinococcus multilocularis | serotonin receptor | 0.0159 | 0.4241 | 0.6631 |
Onchocerca volvulus | 0.0033 | 0.0454 | 0.2591 | |
Loa Loa (eye worm) | hypothetical protein | 0.0058 | 0.1207 | 0.2694 |
Loa Loa (eye worm) | MBCTL1 | 0.0066 | 0.1447 | 0.3228 |
Echinococcus multilocularis | suppression of tumorigenicity 18 protein | 0.0066 | 0.1447 | 0.2056 |
Plasmodium vivax | multidomain scavenger receptor, putative | 0.0024 | 0.0191 | 0.5 |
Brugia malayi | hypothetical protein | 0.0024 | 0.0191 | 0.0427 |
Echinococcus multilocularis | ras gtpase | 0.0167 | 0.4481 | 0.7024 |
Loa Loa (eye worm) | Ras protein let-60 | 0.0167 | 0.4481 | 1 |
Schistosoma mansoni | intermediate filament proteins | 0.0033 | 0.0454 | 0.0268 |
Schistosoma mansoni | lipoxygenase | 0.01 | 0.2468 | 0.2321 |
Schistosoma mansoni | lamin | 0.0033 | 0.0454 | 0.0268 |
Echinococcus multilocularis | polycomb protein SCMH1 | 0.0058 | 0.1207 | 0.1663 |
Schistosoma mansoni | lipoxygenase | 0.0142 | 0.3756 | 0.3635 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.1136 | 0.1547 |
Echinococcus multilocularis | SAM and MBT domain containing protein | 0.0058 | 0.1207 | 0.1663 |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.0454 | 0.1014 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0033 | 0.0454 | 0.1014 |
Echinococcus granulosus | lamin | 0.0033 | 0.0454 | 0.0431 |
Trichomonas vaginalis | GTP-binding protein rit, putative | 0.0167 | 0.4481 | 0.5 |
Schistosoma mansoni | biogenic amine (5HT) receptor | 0.0159 | 0.4241 | 0.4128 |
Echinococcus multilocularis | lamin | 0.0033 | 0.0454 | 0.0431 |
Echinococcus multilocularis | histone acetyltransferase MYST2 | 0.0066 | 0.1447 | 0.2056 |
Entamoeba histolytica | Ras family GTPase | 0.0167 | 0.4481 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (binding) | = 39 nM | In vitro binding affinity was evaluated on alpha-1 adrenergic receptor from rat cerebral cortex by using [3H]-prazosin as radioligand | ChEMBL. | 9888831 |
Ki (binding) | = 39 nM | In vitro binding affinity was evaluated on alpha-1 adrenergic receptor from rat cerebral cortex by using [3H]-prazosin as radioligand | ChEMBL. | 9888831 |
Ki (binding) | = 39.2 nM | In vitro binding affinity against Alpha-1 adrenergic receptor in rat cerebral cortex membrane using [3H]-prazosin as radioligand | ChEMBL. | 9871564 |
Ki (binding) | = 39.2 nM | In vitro binding affinity against Alpha-1 adrenergic receptor in rat cerebral cortex membrane using [3H]-prazosin as radioligand | ChEMBL. | 9871564 |
Ki (binding) | = 127 nM | Binding affinity at 5-hydroxytryptamine 1A (5-HT1A) receptor in rat cerebral cortex using [3H]-8-OH-DPAT as radioligand | ChEMBL. | 9888831 |
Ki (binding) | = 127 nM | In vitro binding affinity against serotonin 5-HT1A receptor in rat cerebral cortex membrane using [3H]-8-OH-DPAT as radioligand | ChEMBL. | 9871564 |
Ki (binding) | = 127 nM | Binding affinity at 5-hydroxytryptamine 1A (5-HT1A) receptor in rat cerebral cortex using [3H]-8-OH-DPAT as radioligand | ChEMBL. | 9888831 |
Ki (binding) | = 127 nM | In vitro binding affinity against serotonin 5-HT1A receptor in rat cerebral cortex membrane using [3H]-8-OH-DPAT as radioligand | ChEMBL. | 9871564 |
Ki (binding) | = 801 nM | In vitro binding affinity towards Dopamine receptor D2 of rat striatal membranes using [3H]- raclopride | ChEMBL. | 9888831 |
Ki (binding) | = 801 nM | In vitro binding affinity against Dopamine receptor D2 in rat striatum membrane using [3H]-raclopride as radioligand | ChEMBL. | 9871564 |
Ki (binding) | = 801 nM | In vitro binding affinity towards Dopamine receptor D2 of rat striatal membranes using [3H]- raclopride | ChEMBL. | 9888831 |
Ki (binding) | = 801 nM | In vitro binding affinity against Dopamine receptor D2 in rat striatum membrane using [3H]-raclopride as radioligand | ChEMBL. | 9871564 |
Potency (functional) | = 5.6234 um | PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of L3MBTL1. (Class of assay: confirmatory) [Related pubchem assays: 485292 (Probe Development Summary for Inhibitors of L3MBTL1)] | ChEMBL. | No reference |
Potency (functional) | = 11.2202 um | PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 11.2202 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 12.5893 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2312, AID2537, AID2702] | ChEMBL. | No reference |
Potency (binding) | = 14.1254 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent). (Class of assay: confirmatory) [Related pubchem assays: 2158 (Confirmation qHTS Assay for Inhibitors of Cruzain), 2249 (Probe Development Summary of Promiscuous Inhibitors (Artifacts) of Cruzain), 2161 (qHTS Assay for Inhibitors of Papain: Counterscreen for Cruzain Assay), 1478 (qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent))] | ChEMBL. | No reference |
Potency (functional) | 31.6228 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 32.6427 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 63.0957 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402] | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.